BNGO – Bionano Genomics, Inc.
Bionano Genomics, Inc.BNGO
$0.1934Name : Bionano Genomics, Inc.
Sector : Healthcare
Industry: Medical Instruments & Supplies
Mark. Cap: $27,041,960.00
EPSttm : -2.3
Bionano Genomics, Inc.
$0.1934
5.89%$0.0121Float Short %
12.69
Margin Of Safety %
Put/Call OI Ratio
0.02
EPS Next Q Diff
EPS Last/This Y
5.8
EPS This/Next Y
0.53
Price
0.19
Target Price
1
Analyst Recom
3
Performance Q
-41.96
Relative Volume
0.95
Beta
2.21
Ticker: BNGO
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | BNGO | 0.2021 | 0.03 | 0.08 | 43905 |
| 2024-12-20 | BNGO | 0.2 | 0.03 | 0.08 | 44028 |
| 2024-12-23 | BNGO | 0.2001 | 0.03 | 0.03 | 42790 |
| 2024-12-24 | BNGO | 0.2 | 0.03 | 0.00 | 43155 |
| 2024-12-26 | BNGO | 0.2121 | 0.03 | 0.01 | 43212 |
| 2024-12-27 | BNGO | 0.212 | 0.03 | 0.00 | 42530 |
| 2024-12-30 | BNGO | 0.2782 | 0.03 | 0.01 | 42664 |
| 2024-12-31 | BNGO | 0.2873 | 0.02 | 0.09 | 46519 |
| 2025-01-02 | BNGO | 0.255 | 0.02 | 0.01 | 49749 |
| 2025-01-03 | BNGO | 0.322 | 0.02 | 0.01 | 51075 |
| 2025-01-06 | BNGO | 0.2732 | 0.02 | 0.02 | 56500 |
| 2025-01-07 | BNGO | 0.2717 | 0.02 | 0.00 | 57149 |
| 2025-01-08 | BNGO | 0.2283 | 0.02 | 0.01 | 57981 |
| 2025-01-09 | BNGO | 0.2273 | 0.02 | 0.01 | 57981 |
| 2025-01-10 | BNGO | 0.2265 | 0.02 | 0.00 | 58493 |
| 2025-01-13 | BNGO | 0.2217 | 0.02 | 0.03 | 58644 |
| 2025-01-14 | BNGO | 0.2052 | 0.02 | 0.03 | 58715 |
| 2025-01-15 | BNGO | 0.1986 | 0.02 | 0.04 | 59044 |
| 2025-01-16 | BNGO | 0.2029 | 0.02 | 0.11 | 59183 |
| 2025-01-17 | BNGO | 0.1898 | 0.02 | 0.10 | 59383 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | BNGO | 0.20 | 85.4 | - | -1.01 |
| 2024-12-20 | BNGO | 0.20 | 85.4 | - | -1.01 |
| 2024-12-23 | BNGO | 0.20 | 85.4 | - | -1.01 |
| 2024-12-24 | BNGO | 0.20 | 85.4 | - | -1.01 |
| 2024-12-26 | BNGO | 0.22 | 85.4 | - | -1.01 |
| 2024-12-27 | BNGO | 0.21 | 85.4 | - | -1.01 |
| 2024-12-30 | BNGO | 0.28 | 85.4 | - | -1.01 |
| 2024-12-31 | BNGO | 0.29 | 85.4 | - | -1.01 |
| 2025-01-02 | BNGO | 0.26 | 85.4 | - | -1.01 |
| 2025-01-03 | BNGO | 0.32 | 85.4 | - | -1.01 |
| 2025-01-06 | BNGO | 0.27 | 85.4 | - | -1.01 |
| 2025-01-07 | BNGO | 0.27 | 85.4 | - | -1.01 |
| 2025-01-08 | BNGO | 0.23 | 85.4 | - | -1.01 |
| 2025-01-09 | BNGO | 0.23 | 85.4 | - | -1.01 |
| 2025-01-10 | BNGO | 0.23 | 85.4 | - | -1.01 |
| 2025-01-13 | BNGO | 0.22 | 85.4 | - | -1.01 |
| 2025-01-14 | BNGO | 0.21 | 85.4 | - | -1.01 |
| 2025-01-15 | BNGO | 0.20 | 85.4 | - | -1.01 |
| 2025-01-16 | BNGO | 0.21 | 85.4 | - | -1.01 |
| 2025-01-17 | BNGO | 0.19 | 85.4 | - | -1.01 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | BNGO | 0.00 | -18.94 | 12.47 |
| 2024-12-20 | BNGO | 0.00 | -18.94 | 12.47 |
| 2024-12-23 | BNGO | 0.00 | -18.94 | 12.47 |
| 2024-12-24 | BNGO | 0.00 | -18.94 | 12.47 |
| 2024-12-26 | BNGO | 0.00 | -18.94 | 15.61 |
| 2024-12-27 | BNGO | 0.00 | -18.94 | 15.61 |
| 2024-12-30 | BNGO | 0.00 | -18.95 | 15.61 |
| 2024-12-31 | BNGO | 0.00 | -18.95 | 15.61 |
| 2025-01-02 | BNGO | 0.00 | -18.95 | 15.61 |
| 2025-01-03 | BNGO | 0.00 | -18.95 | 15.61 |
| 2025-01-06 | BNGO | 0.00 | -18.95 | 15.61 |
| 2025-01-07 | BNGO | 0.00 | -18.95 | 15.61 |
| 2025-01-08 | BNGO | 0.00 | -18.95 | 15.61 |
| 2025-01-09 | BNGO | 0.00 | -18.95 | 15.61 |
| 2025-01-10 | BNGO | 0.00 | -18.95 | 15.61 |
| 2025-01-13 | BNGO | 0.00 | -14.57 | 12.69 |
| 2025-01-14 | BNGO | 0.00 | -14.57 | 12.69 |
| 2025-01-15 | BNGO | 0.00 | -14.57 | 12.69 |
| 2025-01-16 | BNGO | 0.00 | -14.57 | 12.69 |
| 2025-01-17 | BNGO | 0.00 | -14.57 | 12.69 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.14
Avg. EPS Est. Next Quarter
-0.14
Insider Transactions
Institutional Transactions
-14.57
Beta
2.21
Average Sales Estimate Current Quarter
6
Average Sales Estimate Next Quarter
8
Fair Value
Quality Score
19
Growth Score
45
Sentiment Score
2
Actual DrawDown %
99.9
Max Drawdown 5-Year %
-99.9
Target Price
1
P/E
Forward P/E
PEG
P/S
0.81
P/B
0.35
P/Free Cash Flow
EPS
-2.31
Average EPS Est. Cur. Y
-1.01
EPS Next Y. (Est.)
-0.48
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-407.34
Relative Volume
0.95
Return on Equity vs Sector %
-296.9
Return on Equity vs Industry %
-287.6
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
EBIT Estimation
Bionano Genomics, Inc.Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 344
Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
stock quote shares BNGO – Bionano Genomics, Inc. Stock Price stock today
news today BNGO – Bionano Genomics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BNGO – Bionano Genomics, Inc. yahoo finance google finance
stock history BNGO – Bionano Genomics, Inc. invest stock market
stock prices BNGO premarket after hours
ticker BNGO fair value insiders trading